Randeep Sangha

137 total papers · 4.8k total citations
72 papers, 2.3k citations indexed

About

Randeep Sangha is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Randeep Sangha has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Randeep Sangha's work include Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (16 papers) and Lymphoma Diagnosis and Treatment (12 papers). Randeep Sangha is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (16 papers) and Lymphoma Diagnosis and Treatment (12 papers). Randeep Sangha collaborates with scholars based in Canada, United States and Germany. Randeep Sangha's co-authors include Charles Butts, Jennifer L. Spratlin, John R. Mackey, Charles Dumontet, James Young, Laith Dabbagh, Darryl Glubrecht, Carol E. Cass, Raymond Lai and Andrew Davies and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Randeep Sangha

70 papers receiving 2.2k citations

Hit Papers

Obinutuzumab for the Firs... 2017 2026 2020 2023 2017 2020 2024 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
    2017 457 citations Robert Marcus, Andrew Davies et al. New England Journal of Medicine profile →
  2. EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
    2020 217 citations Jonathan E. Rosenberg, Srikala S. Sridhar et al. Journal of Clinical Oncology profile →
  3. Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    2024 56 citations Sarah Cook, Daniel E. Meyers et al. JAMA Network Open profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Randeep Sangha 1.3k 583 533 485 368 72 2.3k
Friedrich Prall 1.5k 1.1× 477 0.8× 438 0.8× 396 0.8× 589 1.6× 80 2.4k
Ki Y. Chung 1.6k 1.2× 613 1.1× 705 1.3× 324 0.7× 265 0.7× 62 2.3k
Raymond Tubbs 939 0.7× 817 1.4× 376 0.7× 354 0.7× 302 0.8× 72 2.5k
Dusan Kotasek 1.2k 0.9× 451 0.8× 542 1.0× 370 0.8× 182 0.5× 104 2.3k
Ben Markman 1.2k 0.9× 1.3k 2.3× 488 0.9× 332 0.7× 304 0.8× 75 2.5k
Robert W. Talley 1.1k 0.9× 458 0.8× 723 1.4× 698 1.4× 341 0.9× 53 2.4k
James K. Weick 1.3k 1.0× 895 1.5× 966 1.8× 387 0.8× 240 0.7× 72 3.1k
Ellis Levine 1.1k 0.9× 639 1.1× 941 1.8× 290 0.6× 431 1.2× 91 2.8k
Thomas J. Ervin 1.3k 1.0× 759 1.3× 847 1.6× 474 1.0× 658 1.8× 81 2.9k
Sherri Z. Millis 1.1k 0.8× 768 1.3× 845 1.6× 358 0.7× 430 1.2× 93 2.3k

Countries citing papers authored by Randeep Sangha

Since Specialization
Citations

This map shows the geographic impact of Randeep Sangha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randeep Sangha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randeep Sangha more than expected).

Fields of papers citing papers by Randeep Sangha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randeep Sangha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randeep Sangha. The network helps show where Randeep Sangha may publish in the future.

Co-authorship network of co-authors of Randeep Sangha

This figure shows the co-authorship network connecting the top 25 collaborators of Randeep Sangha. A scholar is included among the top collaborators of Randeep Sangha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randeep Sangha. Randeep Sangha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary Y. Yuen Breakdown of academic impact, for papers by Mikael J. Turunen Breakdown of academic impact, for papers by Heinz Gross Breakdown of academic impact, for papers by D. B. Griffin Breakdown of academic impact, for papers by M. Slaytor Breakdown of academic impact, for papers by W. Hollik Breakdown of academic impact, for papers by Andrés J. Cortés Breakdown of academic impact, for papers by Anthony Newton
Rankless by CCL
2026